13-transmembrane protein expressed in prostate cancer
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Feb 26, 2013
Grant Date -
Jul 24, 2008
app pub date -
Aug 20, 2007
filing date -
Apr 12, 1999
priority date (Note) -
In Force
status (Latency Note)
Importance
Abstract
A novel prostate tumor associated gene (designated 24P4C12) and its encoded protein is described. 24P4C12 is highly expressed in prostate tissue xenografts, providing evidence that it is turned on in at least some prostate cancers. 24P4C12 provides a diagnostic and/or therapeutic target for prostate and other cancers.
First Claim
Family
International Classification(s)
- [Classification Symbol]
- [Patents Count]
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully